Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for #Anaphylm™ for the Treatment of Severe Allergic Reactions

Read the full press release:
investors.aquestive.com/news-release...

#Anaphylaxis #Anaphylactic #Epinephrine #SublingualEpi #SublingualEpinephrine